Phase II study of topotecan in combinati
β
Nobuko Hijiya; Clinton F. Stewart; Yinmei Zhou; Dario Campana; Elaine Coustan-Sm
π
Article
π
2008
π
John Wiley and Sons
π
English
β 109 KB
π 2 views
## Abstract ## BACKGROUND. The authors evaluated the response rate, toxicity, and pharmacokinetics of topotecan given before standard induction therapy for childhood acute lymphoblastic leukemia (ALL) in first relapse. ## METHODS. Patients received topotecan (2.4 mg/m^2^ daily as a 30βminute inf